Pharming receives D180 list of outstanding issues on Rhucin MAA from EU

Pharming receives D180 list of outstanding issues on Rhucin MAA from EU
Biotech company Pharming Group NV has received the Day 180 List of Outstanding Issues (LoOI) from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP).

Read more on PharmaBiz

Living Cell Technologies Receives Grant from JDRFI

Living Cell Technologies Receives Allow from JDRFI
27 April 2010: Sydney, Australia & Auckland, New Zealand. Living Cell Technologies Limited (ASX: LCT; OTCQX: LVCLY), a global company pioneering the development of a cell implant to treat diabetes, has received a allow of US$500,000 for its on-going Phase II clinical trial of DIABECELL® in New Sjaelland from the Juvenile Diabetes Research Foundation International (JDRF), a world leader in setting …

Read more on Scoop.co.nz

Cyprotex Discovery Receives French Research Tax Credit Accreditation

Cyprotex Discovery Receives French Research Tax Credit Accreditation
Cyprotex (AIM:CRX), the drug discovery technology and information company, is pleased to announce that it has received French research tax credit approval for years 2009 through to 2011.

Read more on Thaipr.net

D-Pharm Receives Agreement Letter On Special Protocol Assessment For DP-b99 Study – A Pivotal Phase III Trial In Acute …

D-Pharm Receives Agreement Letter On Special Protocol Assessment For DP-b99 Study – A Pivotal Phase III Trial In Acute …
D-Pharm Ltd (DPRM: TASE) announced that it has reached an agreement with the U.S. Food and Drug Administration (FDA) under the Special Protocol Assessment (SPA) procedure for a pivotal phase 3 trial (MACSI) of its neuroprotective agent DP-b99 in acute ischemic stroke patients. The SPA agreement letter indicates that “the design and planned analysis of the study adequately address the objectives …

Read more on Medical News Today

Beike Biotechnology Receives International Recognition for Quality Control Processes

Beike Biotech Receives International Recognition for Quality Control Processes
TAIZHOU, China, April 2 /PRNewswire-Asia/ — Beike Biotech Co.

Read more on redOrbit